These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25988858

  • 21. Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr mice.
    Papp K, Végh P, Tchorbanov A, Vassilev T, Erdei A, Prechl J.
    Rheumatology (Oxford); 2010 Dec; 49(12):2273-80. PubMed ID: 20736228
    [Abstract] [Full Text] [Related]

  • 22. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
    Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T.
    Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
    [Abstract] [Full Text] [Related]

  • 23. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K, Deng Y, Shang S, Tang L, Li Q, Bai X, Chen X.
    Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
    [Abstract] [Full Text] [Related]

  • 24. Effect of combining ACE inhibitor and statin in lupus-prone mice.
    Shimazu H, Kinoshita K, Hino S, Yano T, Kishimoto K, Nagare Y, Nozaki Y, Sugiyama M, Ikoma S, Funauchi M.
    Clin Immunol; 2010 Aug; 136(2):188-96. PubMed ID: 20403731
    [Abstract] [Full Text] [Related]

  • 25. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
    Gonzalo-Gil E, García-Herrero C, Toldos O, Usategui A, Criado G, Pérez-Yagüe S, Barber DF, Pablos JL, Galindo M.
    Front Immunol; 2018 Aug; 9():1948. PubMed ID: 30210500
    [Abstract] [Full Text] [Related]

  • 26. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019 Aug; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 27. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Complement Properdin Determines Disease Activity in MRL/lpr Mice.
    Alaridhee H, Alharbi A, Saeed Z, Thomas RC, Stover CM.
    Medicina (Kaunas); 2020 Aug 27; 56(9):. PubMed ID: 32867176
    [Abstract] [Full Text] [Related]

  • 31. ALW peptide ameliorates lupus nephritis in MRL/lpr mice.
    Wang H, Lu M, Zhai S, Wu K, Peng L, Yang J, Xia Y.
    Arthritis Res Ther; 2019 Dec 02; 21(1):261. PubMed ID: 31791413
    [Abstract] [Full Text] [Related]

  • 32. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R, Xia Y, Li M, Mao R, Guo C, Zhou M, Tan H, Liu M, Wang S, Yang N, Zhao J.
    Arthritis Rheumatol; 2019 Aug 02; 71(8):1308-1318. PubMed ID: 30791224
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J, Li Q, Yang X, Li M.
    Mol Med; 2015 Apr 15; 21(1):364-70. PubMed ID: 25902303
    [Abstract] [Full Text] [Related]

  • 35. IL-33 neutralization suppresses lupus disease in lupus-prone mice.
    Li P, Lin W, Zheng X.
    Inflammation; 2014 Jun 15; 37(3):824-32. PubMed ID: 24398614
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 38. Anti-C1q autoantibodies in murine lupus nephritis.
    Trouw LA, Seelen MA, Visseren R, Duijs JM, Benediktsson H, de Heer E, Roos A, van Kooten C, Daha MR.
    Clin Exp Immunol; 2004 Jan 01; 135(1):41-8. PubMed ID: 14678263
    [Abstract] [Full Text] [Related]

  • 39. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B, Wu J, Chu YW, Wang Y, Wang DP, Wu HS, Xiong SD.
    Rheumatology (Oxford); 2005 Sep 01; 44(9):1108-14. PubMed ID: 15840592
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.